Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
Amendments only.1–6 of 6
  • PassiveAmendment 2
    Nov 16, 2026
    SABS · SAB Biotherapeutics, Inc.
    Vivo Opportunity Fund Holdings, L.P.
    9.99% · 22,287,501 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    KTTA · Pasithea Therapeutics Corp.
    Vivo Opportunity Fund Holdings, L.P.
    9.99% · 9,202,561 shSEC
  • PassiveAmendment 2Below 5%
    Nov 16, 2026
    DRUG · Bright Minds Biosciences Inc.
    Vivo Opportunity Fund Holdings, L.P.
    3.8% · 378,484 shSEC
  • PassiveAmendment 5
    Nov 16, 2026
    UNCY · Unicycive Therapeutics, Inc.
    Vivo Opportunity Fund Holdings, L.P.
    9.99% · 3,911,375 shSEC
  • PassiveAmendment 2
    Nov 16, 2026
    CAMP · CAMP4 Therapeutics Corporation
    Vivo Opportunity Fund Holdings, L.P.
    9.99% · 7,906,436 shSEC
  • PassiveAmendment 1Below 5%
    Nov 16, 2026
    BLSM · BlossomHill Therapeutics, Inc.
    Vivo Innovation Fund II Holdings, L.P.
    4.7% · 1,493,740 shSEC